1. Home
  2. PYXS vs CODA Comparison

PYXS vs CODA Comparison

Compare PYXS & CODA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PYXS
  • CODA
  • Stock Information
  • Founded
  • PYXS 2018
  • CODA 1994
  • Country
  • PYXS United States
  • CODA United States
  • Employees
  • PYXS N/A
  • CODA N/A
  • Industry
  • PYXS Biotechnology: Pharmaceutical Preparations
  • CODA Industrial Machinery/Components
  • Sector
  • PYXS Health Care
  • CODA Industrials
  • Exchange
  • PYXS Nasdaq
  • CODA Nasdaq
  • Market Cap
  • PYXS 75.0M
  • CODA 85.8M
  • IPO Year
  • PYXS 2021
  • CODA N/A
  • Fundamental
  • Price
  • PYXS $1.10
  • CODA $7.18
  • Analyst Decision
  • PYXS Strong Buy
  • CODA Strong Buy
  • Analyst Count
  • PYXS 5
  • CODA 1
  • Target Price
  • PYXS $9.00
  • CODA $11.00
  • AVG Volume (30 Days)
  • PYXS 387.8K
  • CODA 62.5K
  • Earning Date
  • PYXS 08-13-2025
  • CODA 09-15-2025
  • Dividend Yield
  • PYXS N/A
  • CODA N/A
  • EPS Growth
  • PYXS N/A
  • CODA 21.86
  • EPS
  • PYXS N/A
  • CODA 0.30
  • Revenue
  • PYXS N/A
  • CODA $22,758,966.00
  • Revenue This Year
  • PYXS N/A
  • CODA $30.82
  • Revenue Next Year
  • PYXS N/A
  • CODA $20.84
  • P/E Ratio
  • PYXS N/A
  • CODA $23.93
  • Revenue Growth
  • PYXS N/A
  • CODA 24.78
  • 52 Week Low
  • PYXS $0.83
  • CODA $5.76
  • 52 Week High
  • PYXS $5.39
  • CODA $9.89
  • Technical
  • Relative Strength Index (RSI)
  • PYXS 43.52
  • CODA 41.27
  • Support Level
  • PYXS $1.12
  • CODA $7.50
  • Resistance Level
  • PYXS $1.38
  • CODA $8.00
  • Average True Range (ATR)
  • PYXS 0.08
  • CODA 0.48
  • MACD
  • PYXS -0.01
  • CODA -0.10
  • Stochastic Oscillator
  • PYXS 5.08
  • CODA 3.97

About PYXS Pyxis Oncology Inc.

Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.

About CODA Coda Octopus Group Inc. Common stock

Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. The company's operations are organized into two reportable segments: the Products Segment (Marine Technology Business serving the subsea market and PAL, which sells other products (acoustic hydrophones and acoustic materials to a different market); and the Services Segment (Marine Engineering Business). Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Products segment.

Share on Social Networks: